179 related articles for article (PubMed ID: 37001433)
1. UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus.
Mauro D; Manou-Stathopoulou S; Rivellese F; Sciacca E; Goldmann K; Tsang V; Lucey-Clayton I; Pagani S; Alam F; Pyne D; Rajakariar R; Gordon PA; Whiteford J; Bombardieri M; Pitzalis C; Lewis MJ
J Autoimmun; 2023 Apr; 136():103023. PubMed ID: 37001433
[TBL] [Abstract][Full Text] [Related]
2. Effect of UBE2L3 genotype on regulation of the linear ubiquitin chain assembly complex in systemic lupus erythematosus.
Lewis M; Vyse S; Shields A; Boeltz S; Gordon P; Spector T; Lehner P; Walczak H; Vyse T
Lancet; 2015 Feb; 385 Suppl 1():S9. PubMed ID: 26312912
[TBL] [Abstract][Full Text] [Related]
3. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases.
Lewis MJ; Vyse S; Shields AM; Boeltz S; Gordon PA; Spector TD; Lehner PJ; Walczak H; Vyse TJ
Am J Hum Genet; 2015 Feb; 96(2):221-34. PubMed ID: 25640675
[TBL] [Abstract][Full Text] [Related]
4. High
Wang T; Marken J; Chen J; Tran VB; Li QZ; Li M; Cerosaletti K; Elkon KB; Zeng X; Giltiay NV
Front Immunol; 2019; 10():1243. PubMed ID: 31231380
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
Kim T; Bae SC; Kang C
Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional repressor Gfi1 prevents lupus autoimmunity by restraining TLR7 signaling.
Desnues B; Macedo AB; Ordoñez-Rueda D; Roussel-Queval A; Malissen B; Bruhns P; Malissen M; Alexopoulou L
Eur J Immunol; 2016 Dec; 46(12):2801-2811. PubMed ID: 27600904
[TBL] [Abstract][Full Text] [Related]
7. B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice.
Hwang SH; Lee H; Yamamoto M; Jones LA; Dayalan J; Hopkins R; Zhou XJ; Yarovinsky F; Connolly JE; Curotto de Lafaille MA; Wakeland EK; Fairhurst AM
J Immunol; 2012 Dec; 189(12):5786-96. PubMed ID: 23150717
[TBL] [Abstract][Full Text] [Related]
8. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.
Guiducci C; Gong M; Xu Z; Gill M; Chaussabel D; Meeker T; Chan JH; Wright T; Punaro M; Bolland S; Soumelis V; Banchereau J; Coffman RL; Pascual V; Barrat FJ
Nature; 2010 Jun; 465(7300):937-41. PubMed ID: 20559388
[TBL] [Abstract][Full Text] [Related]
9. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
10. TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.
Zou Z; Du D; Miao Y; Yang Y; Xie Y; Li Z; Zhou L; Zhang L; Zhou P; Jiang F
Int Immunopharmacol; 2020 Aug; 85():106648. PubMed ID: 32504998
[TBL] [Abstract][Full Text] [Related]
11. TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals.
Satterthwaite AB
Curr Rheumatol Rep; 2021 Nov; 23(11):80. PubMed ID: 34817709
[TBL] [Abstract][Full Text] [Related]
12. Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity.
Chodisetti SB; Fike AJ; Domeier PP; Singh H; Choi NM; Corradetti C; Kawasawa YI; Cooper TK; Caricchio R; Rahman ZSM
J Immunol; 2020 Feb; 204(4):796-809. PubMed ID: 31900342
[TBL] [Abstract][Full Text] [Related]
13. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.
Agik S; Franek BS; Kumar AA; Kumabe M; Utset TO; Mikolaitis RA; Jolly M; Niewold TB
J Rheumatol; 2012 Jan; 39(1):73-8. PubMed ID: 22045845
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor signalling in B cells during systemic lupus erythematosus.
Fillatreau S; Manfroi B; Dörner T
Nat Rev Rheumatol; 2021 Feb; 17(2):98-108. PubMed ID: 33339987
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus.
Wen L; Zhang B; Wu X; Liu R; Fan H; Han L; Zhang Z; Ma X; Chu CQ; Shi X
Front Immunol; 2023; 14():1093208. PubMed ID: 36875095
[TBL] [Abstract][Full Text] [Related]
16. Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling.
Giltiay NV; Shu GL; Shock A; Clark EA
Arthritis Res Ther; 2017 May; 19(1):91. PubMed ID: 28506291
[TBL] [Abstract][Full Text] [Related]
17. Lupus Autoimmunity and Metabolic Parameters Are Exacerbated Upon High Fat Diet-Induced Obesity Due to TLR7 Signaling.
Hanna Kazazian N; Wang Y; Roussel-Queval A; Marcadet L; Chasson L; Laprie C; Desnues B; Charaix J; Irla M; Alexopoulou L
Front Immunol; 2019; 10():2015. PubMed ID: 31552019
[TBL] [Abstract][Full Text] [Related]
18. Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation.
Souyris M; Mejía JE; Chaumeil J; Guéry JC
Semin Immunopathol; 2019 Mar; 41(2):153-164. PubMed ID: 30276444
[TBL] [Abstract][Full Text] [Related]
19. Mendelian randomization analysis revealed potential causal factors for systemic lupus erythematosus.
Mo X; Guo Y; Qian Q; Fu M; Lei S; Zhang Y; Zhang H
Immunology; 2020 Mar; 159(3):279-288. PubMed ID: 31670388
[TBL] [Abstract][Full Text] [Related]
20. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
Chauhan SK; Singh VV; Rai R; Rai M; Rai G
J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
